Search

Search Constraints

You searched for: Author/Creator Rubin, David

Search Results

1. A PHASE II OPEN LABEL STUDY OF NEIHULIZUMAB, AN ANTI-CD162 (PSGL-1) ANTIBODY, IN PATIENTS WITH MODERATE TO SEVERE ACTIVE, ANTI-TNFα AND/OR ANTI-INTEGRIN REFRACTORY ULCERATIVE COLITIS. (26th January 2023)

5. ADVERSE CLINICAL OUTCOMES IN PATIENTS WITH CROHN'S DISEASE RECEIVING DIFFERENT SEQUENCES OF FIRST- AND SECOND-LINE BIOLOGIC TREATMENTS: FINDINGS FROM ROTARY. (22nd January 2022)

6. ADVERSE CLINICAL OUTCOMES IN PATIENTS WITH ULCERATIVE COLITIS RECEIVING DIFFERENT SEQUENCES OF FIRST- AND SECOND-LINE BIOLOGIC TREATMENTS: FINDINGS FROM ROTARY. (22nd January 2022)

9. Comparison of administrative/billing data to expected protocol‐mandated chemotherapy exposure in children with acute myeloid leukemia: A report from the Children's Oncology Group. Issue 7 (11th March 2015)